Skip to content

Biorepository to Support Research in Kidney Diseases

Biorepository to Support Research in Kidney Diseases

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04343417
Enrollment
1000
Registered
2020-04-13
Start date
2020-07-28
Completion date
2035-08-01
Last updated
2025-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Interstitial Nephritis, Acute Kidney Injury, Kidney Diseases

Keywords

Kidney, Kidney Disease, Acute Kidney Injury, Kidney biopsy, Kidney Biorepository

Brief summary

To support advances in the understanding of pathophysiology and therapies of kidney diseases by creating a BioBank of kidney tissue, DNA, plasma, and urine from patients with kidney diseases.

Detailed description

A biorepository of human samples to support research to advance understanding of human kidney diseases will be created. Clinically, kidney diseases are detected by blood and urine laboratory tests. However, the underlying cause of kidney disease is often not clear on blood and urine tests. In such cases, a clinician may choose to perform a kidney biopsy to establish the diagnosis. Patients who are scheduled to undergo a kidney biopsy will be invited to participate in this proposed study.

Interventions

None listed

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo a clinically indicated kidney biopsy * English or Spanish speaking

Exclusion criteria

* Under 18 years or age * Known pregnancy * Additional vulnerable individuals (incarcerated, institutionalized, or otherwise unable to participate in the study) * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Histological diagnosis5 yearsHistological diagnosis of kidney disease determined by evaluation by renal pathologists

Secondary

MeasureTime frameDescription
Occurrence of chronic kidney disease, end stage kidney disease or death10 yearsTrack outcomes in participants recruited for up to 10 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026